In this video, health-care analyst David Williamson discusses the day's three biggest losers in this sector, including Express Scripts after comments made during the company's third-quarter earnings call. Was it a company-specific problem, or should competitors such as CVS Caremark be worried over what the future holds? Watch and find out Express Scripts CEO George Paz's outlook -- and catch up on the day's other big movers.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Negative comments on the conference call spurred a sell-off.
Brenton Flynn and David Williamson have no positions in the stocks mentioned above. The Motley Fool owns shares of Express Scripts and WellPoint. Motley Fool newsletter services recommend Express Scripts and WellPoint. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
Elevance Health
ELV
$373.65
(-0.60%)
$-2.26
Express Scripts Holding Company
ESRX
CVS Health
CVS
$66.57
(-0.40%)
$0.27
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week
Is Oscar Health Stock Still a Buy?
Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode... It's Just a Matter of Time
1 Undervalued Growth Stock That Could Go Parabolic Soon
Why Scholar Rock Shares Are Soaring Today
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.